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Introduction
Hepatocellular carcinoma (HCC) is a human cancer with a high mortality rate worldwide [1] [2] [3] .
Although the prognosis for HCC has improved in recent years, the prognosis for advanced disease remains poor [4] [5] [6] [7] [8] [9] . Tumor progression in HCC is associated with altered expression of multiple molecules, including growth factors and their receptors, oncogenes, tumor suppressor genes, and transcription factors 1, 10 . Gaining a better understanding of the molecular mechanisms underlying tumor progression would aid in the development of new therapies for advanced HCC.
The epithelial-mesenchymal transition (EMT) is considered a critical event in the malignant transformation of cancer, especially during metastasis 11, 12 . Several models demonstrating the contribution of EMT to the progression of established tumors in transformed cells have been developed [12] [13] [14] , including HCC cells 15 . Because EMT is characterized by loss of cell-cell adhesion and leads to cell individualization, EMT is known to be involved in increasing cell motility. Normally, adherent junctions connect cells via homotypic interactions mediated by E-cadherin molecules, the prototypic member of the cadherin superfamily. Not surprisingly, therefore, an inverse correlation has been found between expression of E-cadherin and the invasive capacity of a cell 16 . The downregulation of E-cadherin expression is also a major hallmark of EMT and is closely related to the malignant progression of HCC. Loss of E-cadherin expression has been strongly implicated in the progression and metastasis of human cancers [17] [18] [19] . In addition, abnormal expression of E-cadherin is a useful prognostic factor in patients with gastric carcinoma. E-cadherin expression has also been found to be inversely correlated with the expression of certain transcription factors, including slug (SNAI2), snail (SNAI1), and twist homolog 1 (TWIST1) [20] [21] [22] . EMT is induced by several oncogenic pathways, including Src, Ras, Ets, integrin, transforming growth factor-β1, laminin 5, Wnt/β-catenin, and Notch [23] [24] [25] . The process is induced by a complex orchestration of signaling cascades comprising many signaling pathways, making the understanding of its mechanism more challenging.
The transcriptional factor TWIST1 has been shown to play a key role in EMT and metastasis in HCC 15, 20 , and was originally identified as a master regulator of embryonic morphogenesis [26] [27] [28] . Recent studies have also revealed that TWIST1-induced EMT enhances tumor metastasis 29, 30 , and TWIST1 expression enhanced cell migration activity in HCC cell lines 15 . Thus, here, HCC cell lines were divided into low-and high-EMT groups based on SNAI2 and TWIST1 expression.
Runt-related transcription factor 3 (RUNX3) has been reported to be a tumor suppressor gene for gastric cancer 31 . Therefore, it is not surprising that RUNX3 gene expression decreases in HCC and other human malignancies, including those of the colon, lung, pancreas, and bile duct [32] [33] [34] [35] . Several authors have reported that RUNX3 gene and protein expression is decreased in HCC and that loss of RUNX3 expression prevented apoptosis in HCC cells [36] [37] [38] [39] . We also reported that ectopic RUNX3 expression deactivated Notch signaling by decreasing jagged-1 (JAG1) expression in HCC 40 . Based on the morphological changes in an HCC cell line with ectopic RUNX3 expression, we hypothesized that RUNX3 increases cell-cell adhesion in HCC cells. In the present study, we demonstrate that the loss of RUNX3 protein expression results in an EMT-like change via increased expression of JAG1 in HCC.
Material and Methods
Cell lines and culture. were made using phase-contrast microscopy (IMT-2; Olympus, Tokyo, Japan).
Immunocytochemistry analysis. Cells were cultured in a glass chamber (Lab-Tek II;
Nalgene Nunc, Roskilde, Denmark) to a density of approximately 2 × 10 5 cells/mL for 24 h, prior to being fixed for 20 min in 3% freshly hydrolyzed paraformaldehyde in PBS, at room temperature. After washing with PBS, the cells were incubated with anti-E-cadherin antibody (M3613, Dako Japan, Tokyo, Japan) for 30 min at room temperature, and visualized using Oregon Green-conjugated secondary antibody (Invitrogen). Photographs were taken using a fluorescence microscope (BX51, Olympus) equipped with a digital image capturing system (DP50, Olympus).
MTT assay. Cell proliferation activity was assessed using a Ectopic TWIST1 protein expression. Human TWIST1 cDNA was obtained by PCR-based cloning from a normal human placenta cDNA library (Takara Bio Inc., Otsu, Japan) and subcloned into the pcDNA 3.1 expression vector (Invitrogen) 15 . TWIST1 and green fluorescent protein (GFP; control) constructs were transfected into RUNX3-expressing Ectopic RUNX3 expression in HCC cell lines. Ectopic RUNX3 expression was evaluated in endogenous RUNX3-negative HCC cell lines 38 , and the morphological changes were analyzed under phase-contrast microscopy. Ectopic RUNX3 expression changed the morphology of the cells from a fibroblast-like spindle shape to a paving stone, sheet-like structure in Hep3B ( Fig. 2A ) and Huh7 cells (Supplemental Fig. 1 ). These cells showed well-organized cell-cell adhesion, characteristic of epithelial cells. E-cadherin expression was enhanced in the RUNX3-expressing Hep3B cells (Fig. 2B ) or Huh7 cells (data not shown), especially at the cell-cell junction. In contrast, RUNX3 expression did not induce significant morphological changes in HLF ( Fig. 2A) or SK-Hep1 cells (Supplemental Fig.   1 ), neither was E-cadherin expression significantly different in these cells (Fig. 2B ).
RUNX3 protein expression was also confirmed in RUNX3 cDNA-transfected cells (Fig.   2C ). expression suppressed cell growth by 31-38% (Fig. 2D) .
Ectopic
Ectopic RUNX3 protein expression suppressed cell migration in HCC cell lines. The effect of ectopic RUNX3 expression on HCC cell lines was examined in the in vitro wound healing assay, which is commonly used to assess the effects of pro-and anti-migratory agents on cultured cells. RUNX3 expression significantly suppressed cell migration by 70% ± 20% and 63% ± 5% in Hep3B and Huh7 cells, respectively, but not in HLF and SK-Hep1 cells (Fig. 2E) .
Effect of RUNX3 expression on cell migration in the presence of an apoptosis inhibitor.
An apoptosis inhibitor was used to determine if apoptosis-inducing factors affected cell migration activity in ectopic RUNX3 protein-expressing HCC cell lines. Caspase inhibitor IV was observed to inhibit serum starvation-induced apoptosis by 74% in RUNX3-expressing Hep3B cells (Fig. 3A) . However, caspase inhibitor IV did not abrogate the RUNX3-induced reduction in cell migration activity in these cells (Fig. 3B ).
TWIST1 expression abrogated the anti-EMT effect of ectopic RUNX3. RUNX3 appeared to have a weak effect on EMT in TWIST1-positive HCC cell lines. To determine if ectopic
TWIST1 expression affects the anti-EMT effect of RUNX3 expression, TWIST1 cDNA was introduced into the TWIST1-negative HCC cell line Hep3B, causing the cells to transiently express TWIST1 (Fig. 4A ). RUNX3 expression did not have a significant effect on the EMT markers, E-cadherin, N-cadherin, or vimentin in TWIST1-expressing Hep3B cells (Fig. 4A) . Likewise, RUNX3 expression did not have the anti-migratory effect on TWIST1-expressing Hep3B cells (Fig. 4B) .
JAG1 expression. The JAG1 ligand peptide was used to determine if RUNX3 expression is regulated via JAG1. The JAG1 ligand peptide decreased E-cadherin expression in RUNX3-expressing Hep3B cells (Fig. 5) and induced re-expression of N-cadherin and vimentin in RUNX3-expressing Hep3B cells (Fig. 5 ). was a relationship between E-cadherin and RUNX3 expression in HCC tissues, the scores for E-cadherin immunoreactivity were plotted against those for RUNX3 (Fig. 6B ). In general, low E-cadherin expression scores were observed in tissues with low RUNX3
E-cadherin expression correlation with RUNX3 expression in HCC tissues
expression. Statistical analysis revealed that RUNX3 expression and E-cadherin expression were significantly correlated (r = 0.58, P = 0.0025) in low-EMT HCC tissues. Scores for N-cadherin immunoreactivity were also plotted against those for RUNX3 (Fig. 6C) , where high N-cadherin expression scores were observed in tissues with low RUNX3 expression. A significant inverse correlation was found between RUNX3 and N-cadherin expression (r = -0.74, P < 0.0001). Thus, high-EMT HCC tissues showed low expression of E-cadherin and high expression of N-cadherin.
Gene expression profiling analysis in human HCC. A further examination of the correlation between expression of RUNX3 and of EMT markers was conducted by
analyzing the Oncomine datasets. These analyses revealed that JAG1 mRNA expression was negatively correlated with RUNX3 mRNA expression in low-EMT HCC tissues (r = 0.28, P < 0.05) (Fig. 6D ). E-cadherin mRNA expression was also found to be significantly correlated with RUNX3 mRNA expression in low-EMT HCC tissues (r = 0.33, P < 0.05) (Fig. 6D) . mRNA expressions of N-cadherin and vimentin tended to be negatively correlated with RUNX3 mRNA expression, but the correlations were not significant (r = -0.24 and -0.07, respectively) (Fig. 6D) .
Discussion
RUNX3 expression is generally reduced in human HCC tissues 36, 38 . However, the role of Ectopic RUNX3 expression was evaluated in the endogenous RUNX3-negative HCC cell lines Hep3B, Huh7, HLF, and SK-Hep1 (Fig. 2C) . The establishment of RUNX3-expressing cell lines was advantageous in order to elucidate the RUNX3-related molecular mechanism, as they helped to provide additional clarity to the results obtained.
RUNX3 expression is known to cause apoptosis, especially in the absence of FBS 38 , whereas RUNX3-expressing cells can grow in the presence of FBS. Because RUNX3 is a strong apoptosis inducer 38, 44 , the anti-cell migratory effect of RUNX3 could be due to the apoptosis enhanced by serum starvation. Therefore, a caspase inhibitor was employed to eliminate the potential effects of apoptosis on cell migration. The caspase inhibitor successfully abrogated RUNX3-induced apoptosis (Fig. 3A) , but RUNX3-expressing cells did not recover their cell migration activity (Fig. 3B) . Morphological studies also showed that ectopic RUNX3 expression induced phenotypic changes, resulting in the cells adopting a more plate-like shape instead of their normal, spindle-like shape, in the low-EMT HCC cell lines, but not in the high-EMT HCC cell lines. These results are consistent with the cell shapes generally associated with migratory and non-migratory cells. Collectively, these results suggest that RUNX3 is directly connected to the inhibition of cellular migration associated with metastatic cells.
Several studies examined the downregulation of E-cadherin in HCCs by
immunohistochemical analyses [44] [45] [46] . In accordance with these reports, E-cadherin expression was generally reduced in human HCC tissues and was correlated with RUNX3 expression (Fig. 6B) . The strong correlation between RUNX3 and E-cadherin expression suggests that loss of RUNX3 expression may cause reduced E-cadherin expression.
Similarly, RUNX3 was only able to induce E-cadherin expression in low-EMT HCC cell lines (Fig. 2B, 2C ). As TWIST1 is a strong inducer of EMT and reduces E-cadherin expression, RUNX3 had no effect on E-cadherin expression and very little effect on N-cadherin and vimentin expression in high-EMT cells (Fig. 2C) . But, N-cadherin and vimentin expression were reduced by ectopic RUNX3 expression in low-EMT HCC cells.
Expression of N-cadherin was also analyzed in human HCC tissues. N-cadherin expression was inversely related to RUNX3 expression in low-EMT HCC tissues (Fig. 6C ).
The effects of TWIST1 expression on RUNX3-expressing HCC cell lines were examined by transiently expressing the TWIST1 protein in TWIST1-negative Hep3B cells by transfecting TWIST1 cDNA into CAT-and RUNX3-expressing Hep3B cells (Fig. 4A) .
Ectopic RUNX3 protein expression did not have a significant effect on the EMT markers and cell migration activity in TWIST1-expressing cells (Fig. 4B) . Although there is a possibility that TWIST1 and RUNX3 independently act on E-cadherin, N-cadherin, and vimentin expression, the present results suggest that TWIST1 is the more important regulator of these EMT markers. Therefore, a sequence of genetic alterations in the progression of EMT in HCC may be hypothesized based on the frequency of gene alteration in HCC. The loss of RUNX3 protein expression was found in ~90% of HCC tissue samples, while TWIST1 expression was found in ~30% of HCC tissue samples 15, 38 .
Recently, Aleksic et al. also reported that loss of RUNX3 was a frequent, early event in chemical liver carcinogenesis 47 . Various authors have reported that a loss of or decreased expression of RUNX3 is generally found in HCC [37] [38] [39] , suggesting that decreased expression of RUNX3 could be an early event in human HCC. Since TWIST1 expression reduced RUNX3 expression (Fig. 4A) , TWIST1 may interact with RUNX3 to progress EMT in HCC. Further studies are needed to elucidate the detailed mechanism of interaction between RUNX3 and TWIST1 expression.
RUNX3 has also been previously reported to regulate JAG1 expression in HCC cells by suppressing transcription through direct binding to the transcriptional regulatory region of JAG1 40 . To clarify whether RUNX3 regulates EMT in HCC cells through JAG1 expression, the JAG1 ligand peptide was employed. The JAG1 ligand peptide successfully re-induced EMT in RUNX3-expressing Hep3B cells (Fig. 5) .
Because a relatively small number of HCC tissues were analyzed for RUNX3 and EMT marker expression using immunohistochemistry, Oncomine datasets were also analyzed for RUNX3 mRNA expression and the mRNA of EMT markers in low-EMT HCCs (Fig. 6D ).
In accordance with both a previous report 40 and the present results, JAG1 mRNA expression was significantly, negatively correlated with RUNX3 mRNA expression ( Fig.   6D ) and E-cadherin mRNA expression was significantly correlated with RUNX3 mRNA expression (Fig. 6D) . Although significant correlations were not found between RUNX3 mRNA expression and the other EMT markers, N-cadherin mRNA expression and vimentin mRNA expression tended to be inversely related to RUNX3 mRNA expression.
A repressive function of EMT has been found in a study of tumor suppressor genes in which depletion of a retinoblastoma protein induced EMT in a breast cancer cell line 48 .
The present study suggests that other tumor suppressor genes may be similarly involved in EMT. A relationship between RUNX3 expression and EMT was reported by Chang et al., who demonstrated that RUNX3 expression induced claudin expression 49 . The regulatory function of EMT by RUNX3 was also predicted in a prospective review 50 . Herein, we demonstrated that RUNX3 expression regulates EMT through JAG1 expression.
Conclusions
We uncovered a novel function of RUNX3 in regulating EMT in HCC. Our results suggest that loss or decreased expression of RUNX3 induced EMT via inducing JAG1 expression. were collected 48 h after transfection. Immunoblot analyses were performed using antibodies against RUNX3, TWIST1, E-cadherin, N-cadherin, and vimentin.
Figure Legends
Immunoblotting for α-actin levels was used to verify equal loading of cellular proteins. (B,C) RUNX3, E-cadherin, N-cadherin, and TWIST1 protein expression were assessed by immunohistochemical analysis in human HCC tissues and corresponding tumor-free Immunoblot analyses were performed using antibodies against SNAI2, TWIST1, and E-cadherin. Immunoblotting for α-actin levels was used to verify equal loading of cellular proteins. HCC cell lines were divided into 2 groups according to EMT-inducer SNAI2 and TWIST1expression. Representative blots of more than 3 independent experiments are shown. 125x98mm (300 x 300 DPI) Fig. 3 . Effect of an apoptosis inhibitor. Hep3B cells were cultured on glass chamber slides and quiesced, then treated with or without caspase inhibitor IV (100 µM) and 10% fetal bovine serum. (A) Apoptosis was quantified using the DAPI apoptosis detection assay (mock, white bars; RUNX3, black bars). Results are expressed as percent apoptotic cells. Data represent the mean ± SE of more than 3 independent experiments, each performed in triplicate. n.s., P > 0.05; **, P < 0.01 (versus data for mock-transfected cells); Student's t test. (B) Cell migration activities were measured as described in the Material and Methods (mock, white bars; RUNX3, black bars). All results are normalized to data for untreated control cells. Data represent the mean ± SE of more than 3 independent experiments, each performed in triplicate. n.s., P > 0.05; *, P < 0.05; **, P < 0.01 (versus data for mock-transfected cells); Student's t test. 178x278mm (300 x 300 DPI) (B,C) RUNX3, E-cadherin, N-cadherin, and TWIST1 protein expression were assessed by immunohistochemical analysis in human HCC tissues and corresponding tumor-free sections. Plots of the E-cadherin (B) and N-cadherin (C) expression score are shown compared with the RUNX3 expression score. (D) Correlations between RUNX3 expression and EMT markers were analyzed using publicly available microarray data sets (www.oncomine.org). RUNX3, E-cadherin, N-cadherin, vimentin, and JAG1 expression are plotted. The data are shown as arbitrary expression values. A 95% tolerance ellipse for each pair of variables was calculated and plotted.
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